EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking
Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability...
Saved in:
Published in | European psychiatry Vol. 29; p. 1 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Masson SAS
2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0924-9338 1778-3585 |
DOI | 10.1016/S0924-9338(14)78024-1 |
Cover
Abstract | Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse.
134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated.
There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R 2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months.
These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse. |
---|---|
AbstractList | Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse.
134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated.
There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R 2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months.
These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse. Introduction Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse. High cigarette craving has been proposed as a predictor of relapse. A recent study suggests that low inhibitory control capacities (low ability to inhibit prepotent responses) were correlated with high nicotine dependence. In this study, we focused on the link between inhibition capacity, craving, tobacco dependence and relapse. Method 134 smokers willing to quit smoking were consecutively included and followed prospectively. Tobacco dependence was assessed with the Fagerstorm test. We used the Hayling task to measure their inhibitory capacity and a specific questionnaire to measure tobacco craving (TCQ 12). Assessments were performed at baseline, 1, 3 and 6 months after smoking cessation. Any relapse in smoking during the follow-up was evaluated. Results There was an association between lower inhibition capacities and higher dependance level at baseline. Low inhibition capacities were an independent predictor of relapse at 6 months (logit R2 = .08, F (2,134) = 10.851, p <. 004). In contrast, although level of tobacco dependence and craving predicted relapse in the short term (first month), they did not predict relapse at 6 months. Conclusions These results suggest that inhibition capacities may predict smoking relapse in the long term (6 months) better than usual measures of craving. In clinical practice, an inhibition test, which is short and feasible, could be of interest to identify smokers at higher risk of relapse. |
Author | Flaudias, V. Lopez-Castroman, J. Perriot, J. Schmitt, A. Guillaume, S. Llorca, P.M. Picot, M. Quantin, X. Courtet, P. |
Author_xml | – sequence: 1 givenname: V. surname: Flaudias fullname: Flaudias, V. organization: EA NPsy-Sydo, Université d’Auvergne, Clermont-Ferrand, France – sequence: 2 givenname: J. surname: Lopez-Castroman fullname: Lopez-Castroman, J. organization: Pschiatric Emergency and Post Emergency, CHU Montpellier / INSERM U1061 / Fundacion Jimenez Diaz, Montpellier, France – sequence: 3 givenname: P.M. surname: Llorca fullname: Llorca, P.M. organization: Psychiatry, Université d’Auvergne, Clermont-Ferrand, France – sequence: 4 givenname: A. surname: Schmitt fullname: Schmitt, A. organization: EA NPsy-Sydo, Université d’Auvergne, Clermont-Ferrand, France – sequence: 5 givenname: J. surname: Perriot fullname: Perriot, J. organization: Dispensaire Émile Roux, Université d’Auvergne, Clermont-Ferrand, France – sequence: 6 givenname: M. surname: Picot fullname: Picot, M. organization: DIM, CHU Montpellier, Montpellier, France – sequence: 7 givenname: P. surname: Courtet fullname: Courtet, P. organization: Pschiatric Emergency and Post Emergency, CHU Montpellier / INSERM U1061, Montpellier, France – sequence: 8 givenname: X. surname: Quantin fullname: Quantin, X. organization: Respiratory Disease Department, CHU Montpellier / Laboratoire Epsylon, Montpellier, France – sequence: 9 givenname: S. surname: Guillaume fullname: Guillaume, S. organization: Psychiatric Emergency and Post Emergency, CHRU Montpellier / INSERM U1061, Montpellier, France |
BookMark | eNqNkM1KAzEUhYNUsK0-gpClLkZzJzOTZKFSSv2BgoK6cBXSTEbTTidDMird-Q6-oU_iTCsuBNHV5cA9H-ecAepVrjII7QM5AgLZ8S0RcRIJSvkBJIeMk1bBFuoDYzyiKU97qP_9soMGIcwJAUZI1kcPk5tRRLI0wR9v73iq9AK7Atvqyc5s4_wKa1c13pW49ia3usHelKoOpn3BtXF1afCrLUtbPeLG4dC4GoelW7R6F20Xqgxm7-sO0f355G58GU2vL67Go2mkYwCIhII8S3mmxIwKUJzonHJGaZ4VeUqJMCmLVZwyrnKuOVMcmGB8lhElREx5Toco3XC1dyF4U8ja26XyKwlEdvvI9T6yKy8hket9JLS-s43PtOFerPEyaGsq3db0Rjcyd_ZPwukPgm6HsFqVC7MyYe6efdU2lyBDLMkG0jEgWRM6wMnvgH8E-ATBkJYm |
ContentType | Journal Article |
Copyright | 2014 Elsevier Masson SAS Elsevier Masson SAS |
Copyright_xml | – notice: 2014 Elsevier Masson SAS – notice: Elsevier Masson SAS |
DBID | AAYXX CITATION |
DOI | 10.1016/S0924-9338(14)78024-1 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1778-3585 |
EndPage | 1 |
ExternalDocumentID | 10_1016_S0924_9338_14_78024_1 S0924933814780241 1_s2_0_S0924933814780241 |
GroupedDBID | --- --K --M .1- .FO .~1 09C 09E 0R~ 1B1 1P~ 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8FI 8FJ 8P~ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AANRG AAOAW AAQXK AASVR AAXMD AAXUO AAYWO ABBQC ABBZL ABFNM ABGDZ ABIVO ABJNI ABMZM ABUWG ABVKB ABWVN ABXAU ABXDB ABXHF ACAJB ACDAQ ACDLN ACGFS ACHQT ACIUM ACQPF ACRPL ACVFH ACZWT ADAZD ADBBV ADCNI ADDNB ADEZE ADKIL ADMUD ADNMO ADOVH ADVJH ADVLN AEBAK AEKER AENCP AENEX AEUPX AEVXI AEYHU AFKRA AFPKN AFPUW AFRHN AFTJW AFZFC AGABE AGHFR AGJUD AGQPQ AGUBO AGYEJ AHIPN AHRGI AIGII AITUG AJPFC AJRQY AJUYK AKBMS AKMAY AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX AQJOH ASPBG AVWKF AZFZN AZQEC BENPR BLXMC BLZWO CCPQU CCQAD CCUQV CFBFF CGQII CJCSC CS3 DOHLZ DU5 DWQXO EBS EGQIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYUFA G-Q GBLVA GNUQQ GROUPED_DOAJ HVGLF HZ~ IHE IKXGN IOO IPYYG J1W LN9 M2M M41 MO0 N9A NZEOI O-L O9- OAUVE OH0 OK1 OU- OZT P-8 P-9 P2P PC. PHGZM PHGZT PIMPY PSYQQ PUEGO Q38 R2- RCA ROL RPM RPZ SCC SDF SDG SDP SES SEW SSZ UHS UKHRP UV1 WFFJZ Z5R ~G- 0SF AACTN AFCTW AJOXV ALIPV AMFUW NCXOZ RIG T5K AAEED AAQFI ABYKQ AEBPU AJBFU EFLBG LCYCR LW7 AAYXX CITATION |
ID | FETCH-LOGICAL-c2111-9a1d6586a9b391a80cd38733d6fd5309e572a2578ad8c87a817978b60a99238d3 |
IEDL.DBID | .~1 |
ISSN | 0924-9338 |
IngestDate | Tue Jul 01 03:13:43 EDT 2025 Fri Feb 23 02:25:08 EST 2024 Sun Feb 23 10:19:45 EST 2025 Tue Aug 26 16:31:45 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2111-9a1d6586a9b391a80cd38733d6fd5309e572a2578ad8c87a817978b60a99238d3 |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1016_S0924_9338_14_78024_1 elsevier_sciencedirect_doi_10_1016_S0924_9338_14_78024_1 elsevier_clinicalkeyesjournals_1_s2_0_S0924933814780241 elsevier_clinicalkey_doi_10_1016_S0924_9338_14_78024_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014 2014-00-00 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014 |
PublicationDecade | 2010 |
PublicationTitle | European psychiatry |
PublicationYear | 2014 |
Publisher | Elsevier Masson SAS |
Publisher_xml | – name: Elsevier Masson SAS |
SSID | ssj0017006 |
Score | 2.0266488 |
Snippet | Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved in relapse.... Introduction Most patients (70%) discontinuing tobacco smoking will relapse within 6 months. A major challenge is the understanding of the processes involved... |
SourceID | crossref elsevier |
SourceType | Index Database Publisher |
StartPage | 1 |
SubjectTerms | Internal Medicine Psychiatry |
Title | EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0924933814780241 https://www.clinicalkey.es/playcontent/1-s2.0-S0924933814780241 https://dx.doi.org/10.1016/S0924-9338(14)78024-1 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA9jB_EifuL8GDl40EO2Zknb9DjGxhAngg7mKaRNi0XcylrxJv4P_of-Jb6k3aY4GHgN76Xl8T6T93tB6IJrMyXM1UQxc1oVUk5CxhQB4wLXyDT3LVB4dOsNx_x64k5qqLfAwpi2ysr3lz7deutqpV1Js52lafveMaUDVFiU-wIijUWwc9_oeut92eZhxs_Z-0ogJoZ6heIpd7CLl5Rf2U0IXR-ffsScwS7aqZJF3C3_Zw_V4uk-2hpV1-EH6LF_1yUGt4m_Pj7xjYqe8SzB6fQpDVNzeY6rRnSczQ1PgQ1yJctjIMFl6zh-S-1QblzMsJkxgPOXmTk8P0TjQf-hNyTVWwkkghKOkkBRDcmEp4KQBVQJJ9JM-IxpL9Euc4LY9TvKmKfSIhK-EmCIvgg9RwWQ4gnNjlB9OpvGxwgzJ2HC0R3FIsoVkEaJS1mswNQjFQvRQK2FhGRWjsSQq14xEKk0IoWaQlqRStpA3kKOcoH3BA8lwWlvYvTXMcZ5ZWe5pDLvSEf-0YUGEkvOX-q0-aMn_2c9RduQT_HyhOYM1Yv5a3wOOUsRNq1SNm3F_w1NsOG- |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bSsMwNIwJ6ot4xXnNgw_6kK1Z0jZ9HGNj6jYEN5hPIW1aLOI21olv4j_4h36JJ71MxcHA13BOWg7nfgtCF1ybLWG2JoqZbJVPOfEZUwSEC1Qj09xNB4V7facz5Dcje1RCzWIWxrRV5ro_0-mpts5Pajk1a9M4rt1bJnSACItyV4ClgRBojZtnDoCpq2-LPg-zfy4tWAI0MeDfYzzZFenhJeVX6S2ELjdQP4xOextt5d4ibmQ_tINK4XgXrffyevgeemjdNYgZ3MSf7x-4q4InPIlwPH6M_dhUz3HeiY6nM4Mzx2Z0ZZqEAIKz3nH8GqdbufF8gs2SAZw8T0z2fB8N261Bs0PyxxJIADEcJZ6iGrwJR3k-86gSVqCZcBnTTqRtZnmh7daVkU-lRSBcJUASXeE7lvLAxxOaHaDyeDIODxFmVsSEpeuKBZQrAA0im7JQgawHKhSigqoFheQ024khv5vFgKTSkBSCCpmSVNIKcgo6ymLgE1SUBK29CtFdhhgmuaAlksqkLi35hxkqSCwwf_HT6o8e_R_1HG10Br2u7F73b4_RJjhXPEvXnKDyfPYSnoIDM_fPUgb9Akwu4-A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EPA-0654+%E2%80%93+Lack+of+inhibitory+control+predict+relapse+in+people+willing+to+stop+smoking&rft.jtitle=European+psychiatry&rft.au=Flaudias%2C+V&rft.au=Lopez-Castroman%2C+J&rft.au=Llorca%2C+P.M&rft.au=Schmitt%2C+A&rft.date=2014&rft.issn=0924-9338&rft.volume=29&rft.spage=1&rft.epage=1&rft_id=info:doi/10.1016%2FS0924-9338%2814%2978024-1&rft.externalDBID=ECK1-s2.0-S0924933814780241&rft.externalDocID=1_s2_0_S0924933814780241 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09249338%2FS0924933814X7015X%2Fcov150h.gif |